Advisory & fractional support from an oncology insider
Dragon Health provides boutique lifesciences advisory and fractional support for organizations developing and commercializing next-generation molecules
Clarity • Structure • Prosperity
What we doBoutique lifesciences advisory for next-generation oncology molecules
Dragon Health provides fractional and advisory support across the molecule lifecycle from pre-launch/ proof of concept to commercial excellence:
Pre-launch: market assessments, investor & board readiness
Create quality strategic and tactical deliverables
Business case assessments to KOL engagement
Two decades in oncology, now working to drive results for you
Kashif Hasan
Managing Principal
Kashif brings 20 years of cross-functional experience in oncology marketing, sales, forecasting and pricing, with therapeutic-area depth across GI oncology, lung, and hematology including rare and orphan indications. His launch-readiness experience spans blockbuster products across the oncology therapeutic areas
Focus
Drive molecule lifecycle from pre-launch to commercial excellence
Depth
Market Assessments · Market Strategy · Brand Plan · Medical Plan · KOL Engagement · Pricing
Blockbuster experience
Rituxan
Esbriet
Venetoclax
Zepzelca
Gazyva
Ziihera
Education
B.Comm — McGill University
Education
MBA — UC Berkeley, Haas
CapabilitiesSupport across the molecule lifecycle
Deliver on decisions that matter and hands-on operational support that keeps organizational focus
-
Advisory
Excellence in advisory for pivotal decisions that shape a program:
Lifecycle Go / No-Go decisions
Business case assessments
Market sizing & uptake analysis
Brand / Medical / Tactical plan
KOL engagement strategy & identification
Advisory boards
Landscape assessment
-
Fractionals
Embedded support that keeps focus on execution
Fractional Chief of Staff/ Ops Lead
Launch / brand plan support
Forecasting, modeling & scenario generation
Portfolio governance & project management
Board/ Investor readiness
Marketing tactics & PMRC navigation
Market research
KOL Engagement
Therapeutic focusDepth where science is moving
From modality to indication, Dragon Health works at the frontier of oncology innovation.
Immuno-Oncology
•
Precision Oncology
•
Bispecific Antibodies
•
Antibody-Drug Conjugates
•
Cell Therapy
•
Biomarker Strategy
•
Companion Diagnostics
•
GI Oncology
•
Lung Cancer
•
Hematologic Malignancies
•
Lymphoma
•
Multiple Myeloma
•
Rare & Orphan Indications
•
Market Access & HEOR
•
Leukemia
•
Immuno-Oncology • Precision Oncology • Bispecific Antibodies • Antibody-Drug Conjugates • Cell Therapy • Biomarker Strategy • Companion Diagnostics • GI Oncology • Lung Cancer • Hematologic Malignancies • Lymphoma • Multiple Myeloma • Rare & Orphan Indications • Market Access & HEOR • Leukemia •
Why fractionalFree up your time for impact work.
An oncology insider embedded in your team takes on the urgent and time-consuming so your best people can focus on what builds the future.
-
Where leaders create value
Build the future
Strategic planning & portfolio direction
Team hiring & building
Long-term value creation
-
Where time gets lost
The urgent & time-consuming
Vendor management & market-research logistics
Conference planning, travel & scheduling
Administrative & day-to-day execution
Operational and fractional support from an oncology insider frees up your time for impact work
By the numbersDepth that
de-risks your molecule
2
Ways to engage
6
Blockbuster products
3
Core therapeutic areas
20+
Years in oncology
Get in touchLet's talk about your molecule opportunity
kh@dragonhealth.ai
Engagements
Remote · Fractional · Project-based
